Literature DB >> 17012296

Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology.

S Vucic1, D Tian, P Siao Tick Chong, M E Cudkowicz, E T Hedley-Whyte, D Cros.   

Abstract

A 'syringomyelia-like' syndrome has been infrequently reported in neurological disorders such as Tangiers disease and lepromatous leprosy. This study reports a novel 'syringomyelia-like' syndrome in four adult male patients, which we have termed facial onset sensory and motor neuronopathy, or FOSMN syndrome, that appears to have a neurodegenerative aetiology. Clinical, neurophysiological and pathological data of four patients were reviewed, including the autopsy in one patient. Four male patients (mean age at onset 43), initially developed paraesthesiae and numbness in a trigeminal nerve distribution, which slowly progressed to involve the scalp, neck, upper trunk and upper limbs in sequential order. Motor manifestations, including cramps, fasciculations, dysphagia, dysarthria, muscle weakness and atrophy developed later in the course of the illness. Neurophysiological findings revealed a generalized sensory motor neuronopathy of caudally decreasing severity in all four patients. Autopsy in one patient disclosed loss of motoneurons in the hypoglossal nucleus and cervical anterior horns, along with loss of sensory neurons in the main trigeminal sensory nucleus and dorsal root ganglia. FOSMN syndrome appears to be a slowly progressive neurodegenerative disorder, whose pathogenesis remains to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 17012296     DOI: 10.1093/brain/awl258

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Differential trigeminal myelinated and unmyelinated nerve fiber involvement in FOSMN syndrome.

Authors:  Andrea Truini; Vincenzo Provitera; Antonella Biasiotta; Annamaria Stancanelli; Giovanni Antonini; Lucio Santoro; Giorgio Cruccu; Maria Nolano
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

2.  Facial onset sensory motor neuronopathy: not always a slowly progressive disorder.

Authors:  Emanuele Barca; Massimo Russo; Anna Mazzeo; Carmen Terranova; Antonio Toscano; Paolo Girlanda
Journal:  J Neurol       Date:  2013-04-03       Impact factor: 4.849

Review 3.  Facial onset sensory and motor neuronopathy.

Authors:  Qian Zheng; Lan Chu; Liming Tan; Hainan Zhang
Journal:  Neurol Sci       Date:  2016-07-29       Impact factor: 3.307

Review 4.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 5.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

6.  Unexpected prion phenotypes in experimentally transfused animals: predictive models for humans?

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Prion       Date:  2018-08-16       Impact factor: 3.931

7.  Sensory and motor neuronopathy in a patient with the A382P TDP-43 mutation.

Authors:  Jean-Philippe Camdessanché; Véronique V Belzil; Guillemette Jousserand; Guy A Rouleau; Christelle Créac'h; Philippe Convers; Jean-Christophe Antoine
Journal:  Orphanet J Rare Dis       Date:  2011-02-05       Impact factor: 4.123

8.  Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?

Authors:  Florian Schoeberl; Angela Abicht; Clemens Kuepper; Stefanie Voelk; Stefan Sonnenfeld; Matthias Tonon; Annalisa Schaub; Veronika Scholz; Stephanie Kleinle; Hannes Erdmann; Dieter A Wolf; Peter Reilich
Journal:  J Neurol       Date:  2021-11-25       Impact factor: 6.682

Review 9.  Mimics and chameleons in motor neurone disease.

Authors:  Martin R Turner; Kevin Talbot
Journal:  Pract Neurol       Date:  2013-04-24

10.  Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy.

Authors:  Besa Ziso; Tim L Williams; R Jon L Walters; Stephan R Jaiser; Johannes Attems; Udo C Wieshmann; A J Larner; Anu Jacob
Journal:  Case Rep Neurol       Date:  2015-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.